I think there were seven people on the floor. I mean, it was tiny at the time. And I had the opportunity to apply really deep technical science to the portfolio. We had just been given $5.6 billion through the Project BioShield Act. And to be able to make a determination of how do you actually allocate those resources to have the greatest impact to prevent disease and illness from whether it was intentional use of CBRN or whether it was emerging infectious diseases. (07:09–07:14)
CLAIM
Asserts that $5.6 billion was allocated through the Project BioShield Act.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.